DDrare: Database of Drug Development for Rare Diseases

Cls (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
71	Idiopathic osteonecrosis of the femoral head	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03410940 (ClinicalTrials.gov)	January 7, 2011	19/1/2018	PMCF Study of the CLS Brevius Stem With Kinectiv Technology	Post-Market Clinical Follow-Up (PMCF) Study of the CLS Brevius Stem With Kinectiv Technology	Osteoarthritis;Avascular Necrosis;Rheumatoid Arthritis;Femoral Neck Fractures;Prosthesis Failure	Device: CLS Brevius stem with Kinectiv technology	Zimmer Biomet	NULL	Terminated	18 Years	N/A	All	223		Italy;Poland;Spain

71. Idiopathic osteonecrosis of the femoral head [ 3 clinical trials, 5 drugs, (DrugBank: 4 drugs), 4 drug target genes, 10 drug target pathways]

Searched query = "Idiopathic osteonecrosis of the femoral head", "Idiopathic femoral head necrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 3 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03112785 (ClinicalTrials.gov)	March 17, 2011	7/3/2017	Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations	Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease	Primary Hip Osteoarthritis;Secondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory Disease;Bilateral Hip Disease;Surgical Treatment	Device: Total hip arthroplasty (Fitmore or CLS uncemented femoral stem made by Zimmer-Biomet, Warshaw, USA)	Sahlgrenska University Hospital, Sweden	Zimmer Biomet	Active, not recruiting	35 Years	75 Years	All	44	N/A	NULL